The study examined consecutive preterm neonates undergoing laser treatment of ROP in the neonatal intensive care unit. Twenty-two patients received morphine and 13 received fentanyl, and midazolam was also used when necessary. A change in ventilation status was observed in 45.46 percent of morphine patients and 15.39 percent of fentanyl patients, according to the report.
Apneic events were more common in the morphine group. The data suggests that continuous infusion with fentanyl is safer than morphine for preterm infants undergoing ROP laser therapy in the neonatal ICU.
Read the OSN SuperSite report on fentanyl.
Read more on anesthesia:
–ASA Responds to Study on Anesthesia Service Contract Compensation
–Involving Anesthesia in Transparency and ACOs: Q&A With Somnia Chief Medical Officer Dr. Rob Goldstein
–Non-Infiltrative Anesthetics Effective in Treating Transrectal Prostate Biopsy Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.